By contrast, patients with T1DM receiving insulin therapy were reported to have lower fasting FGF21 levels as compared with T2DM patients, although insulin concentrations were comparable between the two diabetic groups [15]. This evidence concerns the gene FGF21 and type 2 diabetes mellitus.